House Speaker Nancy Pelosi is reportedly readying a plan that could limit Americans’ access to lifesaving medicines and impede the development of new treatments for deadly and debilitating diseases. Her plan, a summary of which was leaked last week, would double down on the failures of existing government policies that have contributed to higher health care costs. It would … [Read more...] about Why Pelosi’s Drug Price Control Scheme Is a Prescription for Disaster
From the start of 2017 through the fall of that year, Congress labored to pass legislation to replace large parts of the Affordable Care Act. Ultimately, political obstacles proved insurmountable, and Congress was unable to enact a health reform bill. Soon after that failure, President Trump signed an executive order promoting health care choice and competition and directing the administration to … [Read more...] about Health Reform Progress Beyond Repeal and Replace
Responding to popular anxiety over prescription drug prices, the Senate Finance Committee last month approved a bill to restructure the Medicare prescription drug benefit. The bill is part of broader congressional and administration efforts to address rising health care costs, one in which lawmakers are laying aside partisan differences to seek constructive solutions. The … [Read more...] about Good and Bad Ideas in the Senate’s Medicare Drug Bill
Galen Senior Fellow Doug Badger has a new paper out this week, published by The Heritage Foundation, showing how a few states that gained waivers to escape some of Obamacare’s expensive, restrictive mandates are helping to lower health insurance premiums for their residents. In his new paper, “How Health Care Premiums Are Declining in States That Seek Relief from Obamacare’s … [Read more...] about How Health Care Premiums Are Declining in States That Seek Relief from Obamacare’s Mandates
The Galen Institute is delighted to announce that former presidential advisor Brian Blase is joining the Galen Institute as a Senior Fellow. Until last month, Brian served on the White House’s National Economic Council where he succeeded in implementing important health policy initiatives, including Health Reimbursement Arrangements, Short-Term Limited-Duration Health Plans, Association … [Read more...] about New Scholar Joins Galen Institute, Pens WSJ Piece!